These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2851995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of hormones on N-(4-hydroxyphenyl) retinamide inhibition of 7,12-dimethylbenz[alpha]anthracene transformation of mammary cells in organ culture.
    Chatterjee M, Banerjee MR.
    Cancer Lett; 1982 Sep; 16(3):239-45. PubMed ID: 6217889
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E, Samuel W, Duncan T, Gutierrez DB, Mata NL, Redmond TM.
    PLoS One; 2017 Sep; 12(4):e0176487. PubMed ID: 28448568
    [Abstract] [Full Text] [Related]

  • 6. Role of hormones on the induction of retinoic acid binding protein in mouse mammary gland organ culture.
    Mehta RG, Moon RC.
    Carcinogenesis; 1985 Aug; 6(8):1103-7. PubMed ID: 2990755
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
    Bunk MJ, Kinahan JJ, Sarkar NH.
    Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
    [Abstract] [Full Text] [Related]

  • 9. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [Abstract] [Full Text] [Related]

  • 10. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS, Shao ZM, Li XS, Ordonez JV, Conley BA, Wu S, Dawson MI, Han QX, Chao WR, Quick T.
    Carcinogenesis; 1995 Oct 01; 16(10):2477-86. PubMed ID: 7586155
    [Abstract] [Full Text] [Related]

  • 11. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
    Hultin TA, McCormick DL, May CM, Moon RC.
    Drug Metab Dispos; 1988 Oct 01; 16(6):783-8. PubMed ID: 2907453
    [Abstract] [Full Text] [Related]

  • 12. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
    Moon RC, Pritchard JF, Mehta RG, Nomides CT, Thomas CF, Dinger NM.
    Carcinogenesis; 1989 Sep 01; 10(9):1645-9. PubMed ID: 2527636
    [Abstract] [Full Text] [Related]

  • 13. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL.
    Clin Cancer Res; 2003 Oct 01; 9(12):4606-13. PubMed ID: 14555536
    [Abstract] [Full Text] [Related]

  • 14. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A, Shilkaitis A, Christov K.
    Carcinogenesis; 1999 Aug 01; 20(8):1535-40. PubMed ID: 10426803
    [Abstract] [Full Text] [Related]

  • 15. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats.
    Radcliffe JD, Moon RC.
    Proc Soc Exp Biol Med; 1983 Nov 01; 174(2):270-5. PubMed ID: 6227008
    [Abstract] [Full Text] [Related]

  • 16. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
    McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC.
    Cancer Res; 1982 Feb 01; 42(2):508-12. PubMed ID: 6459843
    [Abstract] [Full Text] [Related]

  • 17. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
    Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman SM.
    Clin Cancer Res; 2003 Jul 01; 9(7):2400-5. PubMed ID: 12855611
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
    Welsch CW, DeHoog JV, Moon RC.
    Carcinogenesis; 1983 Sep 01; 4(9):1185-7. PubMed ID: 6224605
    [Abstract] [Full Text] [Related]

  • 19. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG, Appierto V, Cavadini E, Valsecchi M, Sonnino S, Curley RW, Formelli F.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H, Steiner MG, Mehta RG, Osborne MP, Telang NT.
    Carcinogenesis; 1999 Feb 15; 20(2):229-36. PubMed ID: 10069458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.